Antibody Response to SARS-CoV-2 Vaccination in Patients With Lymphoproliferative Disorders and Plasma Cell Dyscrasias: Anti-Lymphoma Therapy as a Predictive Biomarker of Response to Vaccination

We retrospectively analyzed SARS-CoV-2 vaccination antibody responses in a cohort of 273 patients with lymphoproliferative disorders or plasma cell dyscrasias who were seen at a single tertiary cancer center. Semi-quantitative anti-spike protein serologic testing was performed with enzyme immunoassa...

Descripción completa

Detalles Bibliográficos
Autores principales: Gung, Carol, McGuire, Regina, George, Mercy, Abdulkareem, Abdullateef, Belden, Katherine A., Porcu, Pierluigi, Martinez-Outschoorn, Ubaldo, Binder, Adam F., Chervenova, Inna, Alpdogan, Onder
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300919/
https://www.ncbi.nlm.nih.gov/pubmed/35875166
http://dx.doi.org/10.3389/fonc.2022.840451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300919/
https://www.ncbi.nlm.nih.gov/pubmed/35875166
http://dx.doi.org/10.3389/fonc.2022.840451

Ejemplares similares